CIPLA Cipla Ltd US FDA Inspections Announcement 2025 - USFDA Inspection Update Cipla Ltd announced that the USFDA inspection of its Medispray facility in Goa, conducted from January 14-20, 2025, has been classified as Voluntary Action Indicated as of April 11, 2025, and was communicated to the company on April 17, 2025. The company states this information is not material but is provided for good governance..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Cipla Ltd